???global.info.a_carregar???
Identification

Personal identification

Full name
I Jolanda M de Vries

Citation names

  • Vries, I

Author identifiers

Ciência ID
5817-E5E3-3350
ORCID iD
0000-0002-8653-4040
Outputs

Publications

Journal article
  1. Worah, K.; Mathan, T. S.; Vu Manh, T. P.; Keerthikumar, S.; Schreibelt, G.; Tel, J.; Duiveman-de Boer, T.; et al. "Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function". Cell Rep 16 11 (2016): 2953-66.
    10.1016/j.celrep.2016.08.023
  2. Vogelaar, I. P.; Ligtenberg, M. J.; van der Post, R. S.; de Voer, R. M.; Kets, C. M.; Jansen, T. J.; Jacobs, L.; et al. "Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect". Fam Cancer 15 2 (2016): 289-96. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000377895600016&KeyUID=WOS:000377895600016.
    10.1007/s10689-015-9859-z
  3. Vasaturo, A.; Halilovic, A.; Bol, K. F.; Verweij, D. I.; Blokx, W. A.; Punt, C. J.; Groenen, P. J.; et al. "T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines". Cancer Res 76 12 (2016): 3496-506.
    10.1158/0008-5472.CAN-15-3211
  4. Bol, K. F.; Aarntzen, E. H.; Hout, F. E.; Schreibelt, G.; Creemers, J. H.; Lesterhuis, W. J.; Gerritsen, W. R.; et al. "Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination". Oncoimmunology 5 1 (2016): e1057673-e1057673.
    10.1080/2162402X.2015.1057673
  5. van Beek, J. J.; Gorris, M. A.; Sköld, A. E.; Hatipoglu, I.; Van Acker, H. H.; Smits, E. L.; de Vries, I. J.; Bakdash, G.. "Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity". Oncoimmunology 5 10 (2016): e1227902-e1227902.
    10.1080/2162402X.2016.1227902
  6. Di Blasio, S.; Wortel, I. M.; van Bladel, D. A.; de Vries, L. E.; Duiveman-de Boer, T.; Worah, K.; de Haas, N.; et al. "Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death". Oncoimmunology 5 8 (2016): e1192739-e1192739.
    10.1080/2162402X.2016.1192739
  7. Boudewijns, S.; Westdorp, H.; Koornstra, R. H.; Aarntzen, E. H.; Schreibelt, G.; Creemers, J. H.; Punt, C. J.; et al. "Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients". J Immunother 39 6 (2016): 241-8.
    10.1097/CJI.0000000000000127
  8. Boudewijns, S.; Bloemendal, M.; Gerritsen, W. R.; de Vries, I. J.; Schreibelt, G.. "Dendritic cell vaccination in melanoma patients: From promising results to future perspectives". Hum Vaccin Immunother (2016): 1-6.
    10.1080/21645515.2016.1197453
  9. Bol, K. F.; Schreibelt, G.; Gerritsen, W. R.; de Vries, I. J.; Figdor, C. G.. "Dendritic Cell-Based Immunotherapy: State of the Art and Beyond". Clin Cancer Res 22 8 (2016): 1897-906.
    10.1158/1078-0432.CCR-15-1399
  10. Schreibelt, G.; Bol, K. F.; Westdorp, H.; Wimmers, F.; Aarntzen, E. H.; Duiveman-de Boer, T.; van de Rakt, M. W.; et al. "Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells". Clin Cancer Res 22 9 (2016): 2155-66.
    10.1158/1078-0432.CCR-15-2205
  11. Bakdash, G.; Buschow, S. I.; Gorris, M. A.; Halilovic, A.; Hato, S. V.; Sköld, A. E.; Schreibelt, G.; et al. "Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines". Cancer Res 76 15 (2016): 4332-46.
    10.1158/0008-5472.CAN-15-1695
  12. Vasaturo, A.; Di Blasio, S.; Verweij, D.; Blokx, W. A.; van Krieken, J. H.; de Vries, I. J.; Figdor, C. G.. "Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma". Histopathology (2016):
    10.1111/his.13070
  13. Westdorp, H.; Fennemann, F. L.; Weren, R. D.; Bisseling, T. M.; Ligtenberg, M. J.; Figdor, C. G.; Schreibelt, G.; et al. "Opportunities for immunotherapy in microsatellite instable colorectal cancer". Cancer Immunol Immunother 65 10 (2016): 1249-59.
    10.1007/s00262-016-1832-7
  14. Tel, J.; Koornstra, R.; de Haas, N.; van Deutekom, V.; Westdorp, H.; Boudewijns, S.; van Erp, N.; et al. "Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition". J Transl Med 14 (2016): 88-88.
    10.1186/s12967-016-0844-6
  15. Bol, K. F.; Aarntzen, E. H.; Pots, J. M.; Olde Nordkamp, M. A.; van de Rakt, M. W.; Scharenborg, N. M.; de Boer, A. J.; et al. "Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity". Cancer Immunol Immunother 65 3 (2016): 327-39.
    10.1007/s00262-016-1796-7
  16. De Vries, J.; Figdor, C.. "Immunotherapy: Cancer vaccine triggers antiviral-type defences". Nature 534 7607 (2016): 329-31. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000377856800022&KeyUID=WOS:000377856800022.
    10.1038/nature18443.
  17. de Haas, N.; de Koning, C.; Spilgies, L.; de Vries, I. J.; Hato, S. V.. "Improving cancer immunotherapy by targeting the STATe of MDSCs". Oncoimmunology 5 7 (2016): e1196312-e1196312.
    10.1080/2162402X.2016.1196312
  18. Boudewijns, S.; Koornstra, R. H.; Westdorp, H.; Schreibelt, G.; van den Eertwegh, A. J.; Geukes Foppen, M. H.; Haanen, J. B.; et al. "Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination". Oncoimmunology 5 8 (2016): e1201625-e1201625.
    10.1080/2162402X.2016.1201625
  19. Wimmers, F.; Aarntzen, E. H.; Duiveman-deBoer, T.; Figdor, C. G.; Jacobs, J. F.; Tel, J.; de Vries, I. J.. "Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination". Oncoimmunology 5 1 (2016): e1067745-e1067745.
    10.1080/2162402X.2015.1067745
  20. Sittig, S. P.; Bakdash, G.; Weiden, J.; Sköld, A. E.; Tel, J.; Figdor, C. G.; de Vries, I. J.; Schreibelt, G.. "A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets". Mediators Inflamm 2016 (2016): 3605643-3605643.
    10.1155/2016/3605643
  21. Bol, K. F.; van den Bosch, T.; Schreibelt, G.; Mensink, H. W.; Keunen, J. E.; Kiliç, E.; Japing, W. J.; et al. "Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma". Ophthalmology 123 10 (2016): 2265-7.
    10.1016/j.ophtha.2016.06.027
  22. Boudewijns, S.; Bol, K. F.; Schreibelt, G.; Westdorp, H.; Textor, J. C.; van Rossum, M. M.; Scharenborg, N. M.; et al. "Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients". Oncoimmunology 5 7 (2016): e1191732-e1191732.
    10.1080/2162402X.2016.1191732
  23. Dieker, J.; Tel, J.; Pieterse, E.; Thielen, A.; Rother, N.; Bakker, M.; Fransen, J.; et al. "Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis". Arthritis & Rheumatology 68 2 (2016): 462-472. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000368942500023&KeyUID=WOS:000368942500023.
    10.1002/art.39417
  24. Amiri, Houshang; Srinivas, Mangala; Veltien, Andor; van Uden, Mark J.; de Vries, I. Jolanda M.; Heerschap, Arend. "Cell tracking using F-19 magnetic resonance imaging: Technical aspects and challenges towards clinical applications". European Radiology 25 3 (2015): 726-735. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000351226300016&KeyUID=WOS:000351226300016.
    10.1007/s00330-014-3474-5
  25. Willemen, Y.; Van den Bergh, J. M.; Lion, E.; Anguille, S.; Roelandts, V. A.; Van Acker, H. H.; Heynderickx, S. D.; et al. "Engineering monocyte-derived dendritic cells to secrete interferon-alpha enhances their ability to promote adaptive and innate anti-tumor immune effector functions". Cancer Immunol Immunother 64 7 (2015): 831-42. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000356875000004&KeyUID=WOS:000356875000004.
    10.1007/s00262-015-1688-2
  26. Prinsen, H.; van Laarhoven, H. W.; Pots, J. M.; Duiveman-de Boer, T.; Mulder, S. F.; van Herpen, C. M.; Jacobs, J. F.; et al. "Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue". Hum Vaccin Immunother 11 7 (2015): 1634-40.
    10.1080/21645515.2015.1040207.
  27. Vasaturo, A.; Verweij, D.; Heinzerling, L.; de Vries, J.; Blokx, W.; Figdor, C. G.. "Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients". Journal of Translational Medicine 13 Suppl 1 (2015): P12-P12.
    10.1186/1479-5876-13-S1-P12.
  28. Prinsen, Hetty; van Laarhoven, Hanneke W. M.; Pots, Jeanette M.; Duiveman-de Boer, Tjitske; Mulder, Sasja F.; van Herpen, Carla M. L.; Jacobs, Joannes F. M.; et al. "Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood". Human Vaccines & Immunotherapeutics 11 7 (2015): 1634-1640. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000357412800021&KeyUID=WOS:000357412800021.
    10.1080/21645515.2015.1040207
  29. Vasaturo, A.; Verdoes, M.; de Vries, J.; Torensma, R.; Figdor, C. G.. "Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment". Immunobiology 220 2 (2015): 243-8. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000346758700011&KeyUID=WOS:000346758700011.
    10.1016/j.imbio.2014.11.007
  30. Kreutz, M.; Bakdash, G.; Dolen, Y.; Skold, A. E.; van Hout-Kuijer, M. A.; de Vries, I. J.; Figdor, C. G.. "Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists". Eur J Immunol 45 10 (2015): 2798-809. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000362554800012&KeyUID=WOS:000362554800012.
    10.1002/eji.201545583
  31. Bol, Kalijn F.; Figdor, Carl G.; Aarntzen, Erik H. J. G.; Welzen, Marieke E. B.; van Rossum, Michelle M.; Blokx, Willeke A. M.; van de Rakt, Mandy W. M. M.; et al. "Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients". Oncoimmunology 4 8 (2015): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000360239300009&KeyUID=WOS:000360239300009.
    10.1080/2162402x.2015.1019197
  32. Srinivas, Mangala; Tel, Jurjen; Schreibelt, Gerty; Bonetto, Fernando; Cruz, Luis-Javier; Amiri, Houshang; Heerschap, Arend; Figdor, Carl G.; De Vries, I. Jolanda M.. "PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by F-19 MRI". Nanomedicine 10 15 (2015): 2339-2348. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000360222600005&KeyUID=WOS:000360222600005.
    10.2217/nnm.15.76
  33. Sittig, S. P.; De Vries, I. J.; Schreibelt, G.. "Primary human blood dendritic cells for cancer immunotherapy – tailoring the immune response by dendritic cell maturation". Biomedicines 3 4 (2015): 282-303.
  34. Skold, A. E.; van Beek, J. J.; Sittig, S. P.; Bakdash, G.; Tel, J.; Schreibelt, G.; de Vries, I. J.. "Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets". Cancer Immunol Immunother 64 11 (2015): 1461-73. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000363247400010&KeyUID=WOS:000363247400010.
    10.1007/s00262-015-1746-9
  35. Sittig, S. P.; De Vries, I. J.; Schreibelt, G.. "Primary human blood dendritic cells for cancer immunotherapy – tailoring the immune response by dendritic cell maturation". Biomedicines 3 4 (2015): 282-303.
  36. van Beek, Jasper J. P.; Wimmers, Florian; Hato, Stanleyson V.; de Vries, I. Jolanda M.; Skold, Annette E.. "Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination". Critical Reviews in Immunology 34 6 (2014): 517-536. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000348413900006&KeyUID=WOS:000348413900006.
    10.1615/CritRevImmunol.2014012204
  37. Wimmers, Florian; Aarntzen, Erik H. J. G.; Schreibelt, Gerty; Jacobs, Joannes F. M.; Punt, Cornelis J. A.; Figdor, Carl G.; de Vries, I. Jolanda M.. "Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy". Oncoimmunology 3 (2014): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000339952700004&KeyUID=WOS:000339952700004.
    10.4161/onci.27219
  38. Wimmers, Florian; Schreibelt, Gerty; Skold, Annette E.; Figdor, Carl G.; De Vries, I. Jolanda M.. "Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets". Frontiers in immunology 5 (2014): 165-165. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:24782868&KeyUID=MEDLINE:24782868.
    10.3389/fimmu.2014.00165
  39. Melief, Cornelis J. M.; Scheper, Rik J.; de Vries, I. Jolanda M.. "Scientific contributions toward successful cancer immunotherapy in The Netherlands". Immunology Letters 162 2 (2014): 121-126. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000347264300005&KeyUID=WOS:000347264300005.
    10.1016/j.imlet.2014.10.012
  40. Tel, Jurjen; Anguille, Sebastien; Waterborg, Claire E. J.; Smits, Evelien L.; Figdor, Carl G.; de Vries, I. Jolanda M.. "Tumoricidal activity of human dendritic cells". Trends in Immunology 35 1 (2014): 38-46. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000330159900006&KeyUID=WOS:000330159900006.
    10.1016/j.it.2013.10.007
  41. Westdorp, Harm; Skold, Annette E.; Snijer, Berit A.; Franik, Sebastian; Mulder, Sasja F.; Major, Pierre P.; Foley, Ronan; Gerritsen, Winald R.; de Vries, I. Jolanda M.. "Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens". Frontiers in immunology 5 (2014): 191-191. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:24834066&KeyUID=MEDLINE:24834066.
    10.3389/fimmu.2014.00191
  42. Bol, Kalijn F.; Mensink, Hanneke W.; Aarntzen, Erik H. J. G.; Schreibelt, Gerty; Keunen, Jan E. E.; Coulie, Pierre G.; De Klein, Annelies; et al. "Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients". American Journal of Ophthalmology 158 5 (2014): 939-947. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000343783400012&KeyUID=WOS:000343783400012.
    10.1016/j.ajo.2014.07.014
  43. Hato, Stanleyson V.; Andrea, Khong; de Vries, I. Jolanda M.; Lesterhuis, W. Joost. "Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics". Clinical Cancer Research 20 11 (2014): 2831-2837. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000337157000003&KeyUID=WOS:000337157000003.
    10.1158/1078-0432.ccr-13-3141
  44. Bakdash, Ghaith; Sittig, Simone P.; van Dijk, Tjeerd; Figdor, Carl G.; de Vries, I. Jolanda M.. "The nature of activatory and tolerogenic dendritic cell-derived signal II". Frontiers in immunology 4 (2013): 53-53. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:23450201&KeyUID=MEDLINE:23450201.
    10.3389/fimmu.2013.00053
  45. Aarntzen, Erik H. J. G.; Srinivas, Mangala; Schreibelt, Gerty; Heerschap, Arend; Punt, Cornelius J. A.; Figdor, Carl G.; Oyen, Wim J.; de Vries, I. Jolanda M.. "Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination". Oncoimmunology 2 7 (2013): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000324588300015&KeyUID=WOS:000324588300015.
    10.4161/onci.24661
  46. Aarntzen, Erik H. J. G.; De Vries, I. Jolanda M.; Lesterhuis, W. Joost; Schuurhuis, Danita; Jacobs, Joannes F. M.; Bol, Kalijn; Schreibelt, Gerty; et al. "Targeting CD4(+) T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination". Cancer Research 73 1 (2013): 19-29. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313019800004&KeyUID=WOS:000313019800004.
    10.1158/0008-5472.can-12-1127
  47. Aarntzen, Erik H. J. G.; Srinivas, Mangala; Bonetto, Fernando; Cruz, Luis J.; Verdijk, Pauline; Schreibelt, Gerty; van de Rakt, Mandy; et al. "Targeting of In-111-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells". Clinical Cancer Research 19 6 (2013): 1525-1533. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000316188900024&KeyUID=WOS:000316188900024.
    10.1158/1078-0432.ccr-12-1879
  48. Tel, Jurjen; Sittig, Simone P.; Blom, Rebecca A. M.; Cruz, Luis J.; Schreibelt, Gerty; Figdor, Carl G.; de Vries, I. Jolanda M.. "Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion". Journal of Immunology 191 10 (2013): 5005-5012. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000326584600015&KeyUID=WOS:000326584600015.
    10.4049/jimmunol.1300787
  49. Schaft, Niels; Coccoris, Miriam; Drexhage, Joost; Knoop, Christiaan; de Vries, I. Jolanda M.; Adema, Gosse J.; Debets, Reno. "An altered gp100 peptide ligand with decreased binding by TCR and CD8 alpha dissects T cell cytotoxicity from production of cytokines and activation of NFAT". Frontiers in Immunology 4 (2013): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000209374100266&KeyUID=WOS:000209374100266.
    10.3389/fimmu.2013.00270
  50. Aarntzen, Erik H. J. G.; Srinivas, Mangala; Radu, Caius G.; Punt, Cornelis J. A.; Boerman, Otto C.; Figdor, Carl G.; Oyen, Wim J. G.; de Vries, I. Jolanda M.. "In vivo imaging of therapy-induced anti-cancer immune responses in humans". Cellular and Molecular Life Sciences 70 13 (2013): 2237-2257. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000320332600003&KeyUID=WOS:000320332600003.
    10.1007/s00018-012-1159-2
  51. Tel, Jurjen; Aarntzen, Erik H. J. G.; Baba, Tetsuro; Schreibelt, Gerty; Schulte, Barbara M.; Benitez-Ribas, Daniel; Boerman, Otto C.; et al. "Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients". Cancer Research 73 3 (2013): 1063-1075. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000315028300005&KeyUID=WOS:000315028300005.
    10.1158/0008-5472.can-12-2583
  52. Bol, Kalijn F.; Tel, Jurjen; de Vries, I. Jolanda M.; Figdor, Carl G.. "Naturally circulating dendritic cells to vaccinate cancer patients". Oncoimmunology 2 3 (2013): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000329126500032&KeyUID=WOS:000329126500032.
    10.4161/onci.23431
  53. Srinivas, Mangala; Melero, Ignacio; Kaempgen, Eckhart; Figdor, Carl G.; de Vries, I. Jolanda M.. "Cell tracking using multimodal imaging". Contrast Media & Molecular Imaging 8 6 (2013): 432-438. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000328821900003&KeyUID=WOS:000328821900003.
    10.1002/cmmi.1561
  54. Tel, Jurjen; Schreibelt, Gerty; Sittig, Simone P.; Mathan, Till S. M.; Buschow, Sonja I.; Cruz, Luis J.; Lambeck, Annechien J. A.; Figdor, Carl G.; de Vries, I. Jolanda M.. "Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8(+) T cells despite lower Ag uptake than myeloid dendritic cell subsets". Blood 121 3 (2013): 459-467. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313727500009&KeyUID=WOS:000313727500009.
    10.1182/blood-2012-06-435644
  55. Schreibelt, Gerty; Bol, Kalijn F.; Aarntzen, Erik H. J. G.; Gerritsen, Winald R.; Punt, Cornelis J. A.; Figdor, Carl G.; de Vries, I. Jolanda M.. "Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy". Oncoimmunology 2 6 (2013): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000322060900028&KeyUID=WOS:000322060900028.
    10.4161/onci.24440
  56. Hato, Stanleyson V.; de Vries, I. Jolanda M.; Lesterhuis, W. Joost. "STATing the importance of immune modulation by platinum chemotherapeutics". Oncoimmunology 1 2 (2012): 234-236. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000316259200022&KeyUID=WOS:000316259200022.
    10.4161/onci.1.2.18126
  57. Tel, Jurjen; Beenhakker, Niels; Koopman, Gerrit; Hart, Bert't; Mudde, Geert C.; de Vries, I. Jolanda M.. "Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFN alpha secretion". Immunobiology 217 10 (2012): 1017-1024. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000309151400009&KeyUID=WOS:000309151400009.
    10.1016/j.imbio.2012.01.016
  58. Jacobs, Joannes F. M.; Nierkens, Stefan; Figdor, Carl G.; de Vries, I. Jolanda M.; Adema, Gosse J.. "Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?". Lancet Oncology 13 1 (2012): E32-E42. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000299014500021&KeyUID=WOS:000299014500021.
  59. Aarntzen, Erik H. J. G.; Bol, Kalijn; Schreibelt, Gerty; Jacobs, Joannes F. M.; Lesterhuis, W. Joost; Van Rossum, Michelle M.; Adema, Gosse J.; et al. "Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma". Cancer Research 72 23 (2012): 6102-6110. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000311893100004&KeyUID=WOS:000311893100004.
    10.1158/0008-5472.can-12-2479
  60. Buschow, Sonja I.; Lasonder, Edwin; Szklarczyk, Radek; Oud, Machteld M.; de Vries, I. Jolanda M.; Figdor, Carl G.. "Unraveling the human dendritic cell phagosome proteome by organellar enrichment ranking". Journal of Proteomics 75 5 (2012): 1547-1562. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000300924700008&KeyUID=WOS:000300924700008.
    10.1016/j.jprot.2011.11.024
  61. Buschow, Sonja I; Lasonder, Edwin; Szklarczyk, Radek; Oud, Machteld M; de Vries, I Jolanda M; Figdor, Carl G. "Unraveling the human dendritic cell phagosome proteome by organellar enrichment ranking.". Journal of proteomics 75 5 (2012): 1547-62. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:22146474&KeyUID=MEDLINE:22146474.
  62. Aarntzen, Erik H. J. G.; Schreibelt, Gerty; Bol, Kalijn; Lesterhuis, W. Joost; Croockewit, Alexandra J.; de Wilt, Johannes H. W.; van Rossum, Michelle M.; et al. "Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4(+) and CD8(+) T Cells Responses in Stage III and IV Melanoma Patients". Clinical Cancer Research 18 19 (2012): 5460-5470. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000311906600030&KeyUID=WOS:000311906600030.
    10.1158/1078-0432.ccr-11-3368
  63. Schreibelt, Gerty; Klinkenberg, Lieke J. J.; Cruz, Luis J.; Tacken, Paul J.; Tel, Jurjen; Kreutz, Martin; Adema, Gosse J.; et al. "The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3(+) myeloid dendritic cells". Blood 119 10 (2012): 2284-2292. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000301356000018&KeyUID=WOS:000301356000018.
    10.1182/blood-2011-08-373944
  64. Tel, Jurjen; Hato, Stanleyson V.; Torensma, Ruurd; Buschow, Sonja I.; Figdor, Carl G.; Lesterhuis, W. Joost; de Vries, I. Jolanda M.. "The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues". Cancer Immunology Immunotherapy 61 7 (2012): 1101-1111. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000305519700014&KeyUID=WOS:000305519700014.
    10.1007/s00262-011-1189-x
  65. Bonetto, F.; Srinivas, M.; Weigelin, B.; Cruz, L. J.; Heerschap, A.; Friedl, P.; Figdor, C. G.; de Vriesa, I. J. M.. "A large-scale 19F MRI-based cell migration assay to optimize cell therapy". Nmr in Biomedicine 25 9 (2012): 1095-1103. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000307544100009&KeyUID=WOS:000307544100009.
    10.1002/nbm.2774
  66. Weide, Benjamin; Zelba, Henning; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K.; Di Giacomo, Anna Maria; Maio, Michele; et al. "Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis". Journal of Clinical Oncology 30 15 (2012): 1835-1841. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000304427600019&KeyUID=WOS:000304427600019.
    10.1200/jco.2011.40.2271
  67. Tel, Jurjen; van der Leun, Anne M.; Figdor, Carl G.; Torensma, Ruurd; de Vries, I. Jolanda M.. "Harnessing human plasmacytoid dendritic cells as professional APCs". Cancer Immunology Immunotherapy 61 8 (2012): 1279-1288. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000306730700012&KeyUID=WOS:000306730700012.
    10.1007/s00262-012-1210-z
  68. Aarntzen, Erik H. J. G.; Srinivas, Mangala; Punt, Cornelius J. A.; Figdor, Carl G.; Oyen, Wim J. G.; de Vries, I. Jolanda M.. "Insight into the dynamics, localization and magnitude of antigen-specific immune responses by F-18 FLT PET imaging". Oncoimmunology 1 5 (2012): 744-745. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000316274400020&KeyUID=WOS:000316274400020.
    10.4161/onci.19533
  69. Anguille, Sebastien; Lion, Eva; Tel, Jurjen; de Vries, I. Jolanda M.; Coudere, Karen; Fromm, Phillip D.; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.. "Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential". Plos One 7 12 (2012): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313051500015&KeyUID=WOS:000313051500015.
    10.1371/journal.pone.0051851
  70. Andralojc, K.; Srinivas, M.; Brom, M.; Joosten, L.; de Vries, I. J. M.; Eizirik, D. L.; Boerman, O. C.; Meda, P.; Gotthardt, M.. "Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis". Diabetologia 55 5 (2012): 1247-1257. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000302994600006&KeyUID=WOS:000302994600006.
    10.1007/s00125-012-2491-7
  71. Tel, Jurjen; de Vries, I. Jolanda M.. "Potential applications for plasmacytoid dendritic cells in cancer immunotherapy". Immunotherapy 4 10 (2012): 979-982. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000310656300003&KeyUID=WOS:000310656300003.
    10.2217/imt.12.115
  72. Tel, Jurjen; Smits, Evelien L.; Anguille, Sebastien; Joshi, Rubin N.; Figdor, Carl G.; de Vries, I. Jolanda M.. "Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities". Blood 120 19 (2012): 3936-3944. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000311629600015&KeyUID=WOS:000311629600015.
    10.1182/blood-2012-06-435941
  73. Prinsen, Hetty; de Vries, I. Jolanda M.; Torensma, Ruurd; Pots, Jeanette M.; Mulder, Sasja F.; van Herpen, Carla M. L.; Elving, Lammy D.; et al. "Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome". Bmc Immunology 13 (2012): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313037600001&KeyUID=WOS:000313037600001.
    10.1186/1471-2172-13-71
  74. Aarntzen, Erik H. J. G.; de Vries, I. Jolanda M.; Goertz, Joop H.; Beldhuis-Valkis, Marjo; Brouwers, Huberdina M. L. M.; van de Rakt, Mandy W. M. M.; van der Molen, Renate G.; et al. "Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters". Cancer Immunology Immunotherapy 61 11 (2012): 2003-2011. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000310888400010&KeyUID=WOS:000310888400010.
    10.1007/s00262-012-1263-z
  75. Aarntzen, Erik H. J. G.; Srinivas, Mangala; Walczak, Piotr; Janowski, Miroslaw; Heerschap, Arend; de Vries, I. Jolanda M.; Figdor, Carl G.; Bulte, Jeff W. M.; Oyen, Wim J. G.. "In Vivo Tracking Techniques for Cellular Regeneration, Replacement, and Redirection". Journal of Nuclear Medicine 53 12 (2012): 1825-1828. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000312115400004&KeyUID=WOS:000312115400004.
    10.2967/jnumed.112.106146
  76. Tel, Jurjen; Torensma, Ruurd; Figdor, Carl G.; de Vries, I. Jolanda M.. "IL-4 and IL-13 Alter Plasmacytoid Dendritic Cell Responsiveness to CpG DNA and Herpes Simplex Virus-1". Journal of Investigative Dermatology 131 4 (2011): 900-906. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000289035800017&KeyUID=WOS:000289035800017.
    10.1038/jid.2010.410
  77. Cruz, Luis J.; Tacken, Paul J.; Bonetto, Fernando; Buschow, Sonja I.; Croes, Huib J.; Wijers, Mietske; de Vries, I. Jolanda; Figdor, Carl G.. "Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells". Molecular Pharmaceutics 8 2 (2011): 520-531. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000289008600021&KeyUID=WOS:000289008600021.
    10.1021/mp100356k
  78. Lesterhuis, W. Joost; Punt, Cornelis J. A.; Hato, Stanleyson V.; Eleveld-Trancikova, Dagmar; Jansen, Bastiaan J. H.; Nierkens, Stefan; Schreibelt, Gerty; et al. "Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice". Journal of Clinical Investigation 121 8 (2011): 3100-3108. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000293495500021&KeyUID=WOS:000293495500021.
    10.1172/JCI43656
  79. de Vries, I. Jolanda M.; Tel, Jurjen; Benitez-Ribas, Daniel; Torensma, Ruurd; Figdor, Carl G.. "Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses". Molecular Immunology 48 6-7 (2011): 810-817. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288578300002&KeyUID=WOS:000288578300002.
    10.1016/j.molimm.2010.12.022
  80. Mulder, Sasja F.; Jacobs, Joannes F. M.; Nordkamp, Michel A. M. Olde; Galama, Joep M. D.; Desar, Ingrid M. E.; Torensma, Ruurd; Teerenstra, Steven; et al. "Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination". Clinical Cancer Research 17 13 (2011): 4541-4549. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000292446600035&KeyUID=WOS:000292446600035.
    10.1158/1078-0432.CCR-11-0253
  81. Tel, Jurjen; Benitez-Ribas, Daniel; Hoosemans, Sander; Cambi, Alessandra; Adema, Gosse J.; Figdor, Carl G.; Tacken, Paul J.; de Vries, I. Jolanda M.. "DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells". European Journal of Immunology 41 4 (2011): 1014-1023. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288821000015&KeyUID=WOS:000288821000015.
    10.1002/eji.201040790
  82. Aarntzen, Erik H. J. G.; Srinivas, Mangala; De Wilt, Johannes H. W.; Jacobs, Joannes F. M.; Lesterhuis, W. Joost; Windhorst, Albert D.; Troost, Esther G.; et al. "Early identification of antigen-specific immune responses in vivo by [(18)F]-labeled 3 '-fluoro-3 '-deoxy-thymidine ([(18)F]FLT) PET imaging". Proceedings of the National Academy of Sciences of the United States of America 108 45 (2011): 18396-18399. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000296700000050&KeyUID=WOS:000296700000050.
    10.1073/pnas.1113045108
  83. de Vries, I. Jolanda M.; Castelli, Chiara; Huygens, Caroline; Jacobs, Joannes F. M.; Stockis, Julie; Schuler-Thurner, Beatrice; Adema, Gosse J.; et al. "Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents". Clinical Cancer Research 17 4 (2011): 841-848. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000287913200023&KeyUID=WOS:000287913200023.
    10.1158/1078-0432.CCR-10-2227
  84. Bonetto, Fernando; Srinivas, Mangala; Heerschap, Arend; Mailliard, Robbie; Ahrens, Eric T.; Figdor, Carl G.; de Vries, I. Jolanda M.. "A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging". International Journal of Cancer 129 2 (2011): 365-373. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000291603900010&KeyUID=WOS:000291603900010.
    10.1002/ijc.25672
  85. Lesterhuis, W. Joost; de Vries, I. Jolanda M.; Schreibelt, Gerty; Lambeck, Annechien J. A.; Aarntzen, Erik H. J. G.; Jacobs, Joannes F. M.; Scharenborg, Nicole M.; et al. "Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients". Clinical Cancer Research 17 17 (2011): 5725-5735. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000294477600023&KeyUID=WOS:000294477600023.
    10.1158/1078-0432.CCR-11-1261
  86. Desar, Ingrid M. E.; Jacobs, J. (Hans) F. M.; Hulsbergen-vandeKaa, Christina A.; Oyen, Wim J. G.; Mulders, Peter F. A.; van der Graaf, Winette T. A.; Adema, Gosse J.; van Herpen, Carla M. L.; de Vries, I. (Jolanda) J. M.. "Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients". International Journal of Cancer 129 2 (2011): 507-512. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000291603900025&KeyUID=WOS:000291603900025.
    10.1002/ijc.25674
  87. Eich, Christina; de Vries, I. Jolanda M.; Linssen, Peter C. M.; de Boer, Annemiek; Boezeman, Jan B.; Figdor, Carl G.; Cambi, Alessandra. "The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells". Immunology and Cell Biology 89 3 (2011): 458-465. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288539800017&KeyUID=WOS:000288539800017.
    10.1038/icb.2010.103
  88. Lesterhuis, W. Joost; Schreibelt, Gerty; Scharenborg, Nicole M.; Brouwer, H. Mary-lene H.; Gerritsen, Marie-Jeanne P.; Croockewit, Sandra; Coulie, Pierre G.; et al. "Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used". Cancer Immunology Immunotherapy 60 2 (2011): 249-260. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000286463400010&KeyUID=WOS:000286463400010.
    10.1007/s00262-010-0942-x
  89. Srinivas, Mangala; Heerschap, Arend; Ahrens, Eric T.; Figdor, Carl G.; de Vries, I. Jolanda M.. "(19)F MRI for quantitative in vivo cell tracking". Trends in Biotechnology 28 7 (2010): 363-370. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000280082400005&KeyUID=WOS:000280082400005.
    10.1016/j.tibtech.2010.04.002
  90. Lesterhuis, W.; Punt, C. J. A.; Eleveld-Trancikova, D.; Jansen, B. J. H.; Van Herpen, C. M. L.; Kaanders, J. H.; Van Krieken, J. H. J. M.; et al. "A novel mechanism of action of platinum-drugs: breaking STAT6-mediated suppression of immune responses against cancer". Ejc Supplements 8 7 (2010): 206-206. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288460100647&KeyUID=WOS:000288460100647.
    10.1016/s1359-6349(10)72366-1
  91. Lesterhuis, W. J.; de Vries, I. J. M.; Aarntzen, E. A.; de Boer, A.; Scharenborg, N. M.; van de Rakt, M.; van Spronsen, D-J; et al. "A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients". British Journal of Cancer 103 9 (2010): 1415-1421. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000283540300015&KeyUID=WOS:000283540300015.
    10.1038/sj.bjc.6605935
  92. Schreibelt, Gerty; Benitez-Ribas, Daniel; Schuurhuis, Danita; Lambeck, Annechien J. A.; van Hout-Kuijer, Maaike; Schaft, Niels; Punt, Cornelis J. A.; et al. "Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells". Blood 116 4 (2010): 564-574. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000280502800012&KeyUID=WOS:000280502800012.
    10.1182/blood-2009-11-251884